Notifications

Back

Notification settings

Back

Post notifications

Post reactions

Be notified when someone leaves a comment or a reply to your post or comment.

Updates and news

Stay ahead of important updates and news from the site.

Alarm
My account Sign out

ABOUT US

Vision
Mission
Greeting
Social responsibility
Our people

CANCER THERAPEUTICS

Nerlynx®
MUCOSAMIN®
Oncology Portal

DIGITAL THERAPEUTICS

OC Free ®
WEPEACH ®
attune™
SparkRx™

MEDIA

Press Release
IR

Location
Inquiry

한국어
English

BIXINK

ABOUT US

CANCER THERAPEUTICS

DIGITAL THERAPEUTICS

MEDIA

ABOUT US

Vision
Mission
Greeting
Social responsibility
Our people

CANCER THERAPEUTICS

Nerlynx®
MUCOSAMIN®
Oncology Portal

DIGITAL THERAPEUTICS

OC Free ®
WEPEACH ®
attune™
SparkRx™

MEDIA

Press Release
IR

Location
Inquiry

한국어
English

BIXINK

한국어
English

MEDIA

Press Release
IR

Press Release

BIXINK " Breast cancer supplement Nerlynx is available in hospitals"

회사뉴스

9 May 2022

http://www.dailypharmkorea.com/Users/News/NewsView.html?ID=3306

Blue Note Therapeutics and Bixink Enter Licensing Agreement for attune™ and DreAMLand™, Prescription Digital Therapeutics for Mental Well-Being in Cancer Patients BIXINK develops Korea's First Digital Therapeutics for mental disorder in cancer patients

List

Contact │ Privacy

6F, 292 Gangnam-daero, Gangnam-gu, Seoul 06258,

Republic of Korea

Contact │ Privacy

6F, 561 Nonhyeon-ro, Gangnam-gu, Seoul 06125, Republic of Korea [06125]

6F, 561 Nonhyeon-ro, Gangnam-gu, Seoul 06125, Republic of Korea